Coherent Market Insights published a business research report on Glycobiology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Glycobiology Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3639
Glycobiology is a branch of biology that deals with study of function, structure, and biosynthesis of saccharides. Glycoconjugates is the basic classification for carbohydrates covalently linked with other chemical species such as peptides, proteins, lipids and saccharides. It play a vital structural role in connective tissues.
The global glycobiology market is estimated to be valued at US$ 1,165.3 million in 2020 and is expected to exhibit a CAGR of 12.8 % during the forecast period (2020-2027).
Growing prevalence of chronic diseases and launch of product by key companies is driving the global glycobiology market growth during the forecast period.
The growing number of product launches such as mass spectrometry devices, high profile liquid chromatography (HPLC) devices, and others is projected to drive the global glycobiology market growth over the forecast period. For instance, in May 2020, Thermo Fisher Scientific Inc. announced the launch of Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 mass spectrometers. The spectrometers are used for identification of proteins and peptides.
Growing government initiatives to spread awareness regarding glycobiologics are projected to drive the market growth during the forecast period.
Several non-profit and governmental organizations are offering research grants to academia and research laboratories in order to promote glycoscience research in the field of glycobiology, which is projected to drive the segment growth in the global glycobiology market.
For instance, in February 2020, the National Research & Development and Innovation Office of Hungary and the European Regional Development Fund funded a research at the University of Debrecen. The research includes the synthesis of new series of 2-c-(β-d-glucopyranosyl)-pyrimidines and their evaluation as inhibitors of some glycoenzymes.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3639
Global Glycobiology Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe thus the World Health Organization declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 162 million infected individuals worldwide as of May 17Th 2021.
COVID-19 affects the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.
Furthermore, players operating in the global glycobiology market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing drug formulations due to irregularities in transportation. Moreover, distributors are experiencing irregular demand for products from the retailers due to an increase in the number of patients suffering from COVID-19 and other life-threatening disorders.
Global Glycobiology Market: Restraint
The major factors that restrict growth of the global glycobiology market includes complexity in determining protein structure which arises from heterogeneity in glycoprotein and lack of trained professionals for performing glycobiology research.
Key Players
Major players operating in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, Agilent Technologies, Inc.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3639
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Glycobiology Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Glycobiology Industry Impact
Chapter 2 Global Glycobiology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Glycobiology (Volume and Value) by Type
2.3 Global Glycobiology (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Glycobiology Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Glycobiology Market Analysis
Chapter 6 East Asia Glycobiology Market Analysis
Chapter 7 Europe Glycobiology Market Analysis
Chapter 8 South Asia Glycobiology Market Analysis
Chapter 9 Southeast Asia Glycobiology Market Analysis
Chapter 10 Middle East Glycobiology Market Analysis
Chapter 11 Africa Glycobiology Market Analysis
Chapter 12 Oceania Glycobiology Market Analysis
Chapter 13 South America Glycobiology Market Analysis
Chapter 14 Company Profiles and Key Figures in Glycobiology Business
Chapter 15 Global Glycobiology Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Press Release: https://www.coherentmarketinsights.com/press-release/glycobiology-market-2934